2001, FDA and Pharmacology - Pharma Rep Focus

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2001

FDA

Pharmacology

Psychedelic medicines: are they gaining traction in Europe?

European Pharmaceutical Review

APRIL 13, 2023

For example, the relaxed attitude towards cannabis in the Netherlands is well-known and Portugal has decriminalised the possession and consumption of all illicit substances since 2001. The US Food and Drug Administration (FDA) has decided to fast-track psilocybin for depression, with full support from President Biden’s administration.

Medicine

Medicine Food and Drug Administration Doctors Medical

Botanical drugs – what is the best way forward for regulatory and market approval?

European Pharmaceutical Review

JULY 4, 2024

In the US, botanical dietary supplements can be sold without US Food and Drug Administration (FDA) approval, 1 prompting many vendors to promote the use of botanical products as dietary supplements , 2 rather than pursue a path of regulatory approval. 3 Is two too few? 3 Is two too few?

Marketing

Marketing Food and Drug Administration Medicine Prescription

Webinars

The Intersection of AI and Sales: Personalization Without Compromise

MORE WEBINARS

Psychedelic medicines: are they gaining traction in Europe?

Botanical drugs – what is the best way forward for regulatory and market approval?

Webinars

Stay Connected